Insider · CIK 0001713795

Schimmelpennink Evert B.

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001713795

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2026-03-27	LENZLENZ Therapeutics, Inc.P Purchase	Director, President, CEO and Secretary	PPurchase	+28.1K sh	$8.95	+$251K	77,289
2026-01-02	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Secretary	AAward	+358K sh	—	—	358,100
2025-11-20	IBIOiBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2025-06-26	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.8K sh	—	—	14,750
2025-03-07	LENZLENZ Therapeutics, Inc.M Exercise/Conversion	Director, President, CEO and Secretary	MExercise/Conversion	+4,200 sh	$1.04	+$4,368	49,200
2025-03-07	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President, CEO and Secretary	MExercise/Conversion	−4,200 sh	—	—	337,906
2025-01-09	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Secretary	AAward	+279K sh	—	—	279,100
2024-11-21	IBIOiBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,900
2024-07-22	LENZLENZ Therapeutics, Inc.M Exercise/Conversion	Director, President, CEO and Secretary	MExercise/Conversion	+45K sh	$1.04	+$46.8K	45,000
2024-07-22	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President, CEO and Secretary	MExercise/Conversion	−45K sh	—	—	342,106
2024-05-24	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,500
2024-03-21	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Secretary	AAward	+387K sh	—	—	387,106
2024-03-21	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Secretary	AAward	+82.7K sh	—	—	82,723
2024-03-21	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Secretary	AAward	+316K sh	—	—	315,864
2024-03-21	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Secretary	AAward	+475K sh	—	—	475,000
2021-12-09	IBIOiBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+109K sh	—	—	109,000
2021-06-07	IBIOiBio, Inc. · Stock OptionA Award	Director	AAward	+100K sh	—	—	100,000
2020-10-01	Pfenex Inc.U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−16.7K sh	—	—	0
2020-10-01	Pfenex Inc.U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−10K sh	—	—	0
2020-10-01	Pfenex Inc.Stock Option (right to buy)U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−36.3K sh	—	—	0
2020-10-01	Pfenex Inc.Stock Option (right to buy)U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−195K sh	—	—	0
2020-10-01	Pfenex Inc.Stock Option (right to buy)U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−300K sh	—	—	0
2020-10-01	Pfenex Inc.Stock Option (right to buy)U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−225K sh	—	—	0
2020-10-01	Pfenex Inc.Stock Option (right to buy)U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−314K sh	—	—	0
2020-02-03	Pfenex Inc.Stock Option (right to buy)A Award	Director, See Remarks	AAward	+225K sh	—	—	225,000
2019-02-01	Pfenex Inc.Stock Option (right to buy)A Award	Director, See Remarks	AAward	+300K sh	—	—	300,000
2018-09-11	Pfenex Inc.P Purchase	Director, See Remarks	PPurchase	+9,500 sh	$5.04	+$47.9K	26,158
2018-09-11	Pfenex Inc.P Purchase	Director, See Remarks	PPurchase	+500 sh	$5.01	+$2,505	26,658
2018-02-01	Pfenex Inc.A Award	Director, See Remarks	AAward	+27.9K sh	—	—	27,894
2018-02-01	Pfenex Inc.F Tax Payment	Director, See Remarks	FTax Payment	−11.2K sh	$3.38	−$38K	16,658
2018-02-01	Pfenex Inc.Stock Option (right to buy)A Award	Director, See Remarks	AAward	+195K sh	—	—	195,062
2017-09-01	Pfenex Inc.Stock Option (right to buy)A Award	Director, See Remarks	AAward	+314K sh	—	—	313,710
2017-09-01	Pfenex Inc.Stock Option (right to buy)A Award	Director, See Remarks	AAward	+36.3K sh	—	—	36,290

Recent filings

Accepted (ET)
Jun 264
Schimmelpennink Evert B.0001628280-26-045839
SEC(opens sec.gov)
Mar 304
Schimmelpennink Evert B.0001713795-26-000004
SEC(opens sec.gov)
Jan 64
Schimmelpennink Evert B.0001713795-26-000002
SEC(opens sec.gov)
Nov 244
Schimmelpennink Evert B.0001104659-25-115414
SEC(opens sec.gov)
Jun 264
Schimmelpennink Evert B.0001437749-25-021372
SEC(opens sec.gov)
Mar 74
Schimmelpennink Evert B.0001815776-25-000011
SEC(opens sec.gov)
Jan 134
Schimmelpennink Evert B.0001815776-25-000003
SEC(opens sec.gov)
Nov 254
Schimmelpennink Evert B.0001104659-24-122593
SEC(opens sec.gov)
Jul 234
Schimmelpennink Evert B.0001815776-24-000051
SEC(opens sec.gov)
May 294
Schimmelpennink Evert B.0001437749-24-018618
SEC(opens sec.gov)
Mar 254
Schimmelpennink Evert B.0001815776-24-000020
SEC(opens sec.gov)
Dec 134
Schimmelpennink Evert B.0001104659-21-149236
SEC(opens sec.gov)
Jun 94
Schimmelpennink Evert B.0001104659-21-078869
SEC(opens sec.gov)
Oct 54
Schimmelpennink Evert B.0000899243-20-027411
SEC(opens sec.gov)

Companies

Address

3565 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121